Use of a gonadotropin releasing hormone agonist before vaginal surgery for cervical leiomyomas: A report of two cases

J. A. Sims, R. Brzyski, K. Hansen, C. C. Coddington

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Two cases of cervical myoma were treated with combined medical/surgical therapy using a gonadotropin releasing hormone agonist (GnRH-a) and transvaginal cervical myomectomy. Patients were treated with depot GnRH-a (leuprolide acetate) for two months followed by myomectomy. This approach allowed successful treatment with short hospitalization (<24 hours). Potential benefits of this regimen include decreased intraoperative blood loss, outpatient management, decreased morbidity, decreased hospital expense and preservation of reproductive potential by avoiding hysterectomy.

Original languageEnglish (US)
Pages (from-to)660-662
Number of pages3
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume39
Issue number8
StatePublished - 1994
Externally publishedYes

Keywords

  • cervix neoplasms
  • gonadotropins
  • leiomyoma

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Use of a gonadotropin releasing hormone agonist before vaginal surgery for cervical leiomyomas: A report of two cases'. Together they form a unique fingerprint.

Cite this